ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 22 filers reported holding ELIEM THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $419,540 | +605.6% | 59,007 | +171.9% | 0.00% | – |
| Q1 2024 | $59,458 | +2.2% | 21,700 | 0.0% | 0.00% | – |
| Q4 2023 | $58,156 | +1.5% | 21,700 | 0.0% | 0.00% | – |
| Q3 2023 | $57,288 | +3.3% | 21,700 | +9.6% | 0.00% | – |
| Q2 2023 | $55,440 | -3.4% | 19,800 | 0.0% | 0.00% | – |
| Q1 2023 | $57,420 | -59.5% | 19,800 | -50.0% | 0.00% | – |
| Q4 2022 | $141,768 | +121.5% | 39,600 | +100.0% | 0.00% | – |
| Q3 2022 | $64,000 | +6.7% | 19,800 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -92.5% | 19,800 | -79.2% | 0.00% | – |
| Q1 2022 | $798,000 | -18.1% | 95,070 | +2.1% | 0.00% | – |
| Q4 2021 | $974,000 | -37.1% | 93,079 | +8.1% | 0.00% | – |
| Q3 2021 | $1,548,000 | – | 86,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,150,849 | $39,716,000 | 1.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 713,009 | $2,153,000 | 0.66% |
| Parkwood LLC | 67,202 | $203,000 | 0.04% |
| Atom Investors LP | 26,309 | $79,000 | 0.04% |
| Woodline Partners LP | 373,368 | $1,128,000 | 0.02% |
| Chicago Partners Investment Group LLC | 23,665 | $75,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 30,619 | $92,000 | 0.00% |
| Ergoteles LLC | 26,364 | $80,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,423 | $62,000 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 59 | $0 | 0.00% |